9:34 AM ET
Earnings Call
▶ Call
Cerenome Earnings Call: Key Takeaways
Cerenome is transitioning to a commercial-stage entity with CNSide diagnostic revenue scaling and Rheobic radiopharmaceutical trials meeting key safety and enrollment milestones for 2027 readouts.
- Call
- Nov 16, 2026, 8:30 AM ET